Siena, Italy

Luca Parente


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Luca Parente in Anti-inflammatory Peptides

Introduction

Luca Parente is an accomplished inventor based in Siena, Italy. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic agents for inflammatory conditions. His work focuses on synthetic peptides derived from human lipocortin V, showcasing his expertise in medicinal chemistry.

Latest Patents

Luca Parente holds a patent for an anti-inflammatory peptide derived from human lipocortin V. The synthetic peptide, with the formula (I) H-Ser-His-Leu-Arg-Lys-Val-Phe-Asp-Lys-OH (SEQ ID NO. 1), is recognized for its novel properties. This peptide demonstrates the capability to inhibit the release of prostaglandin E2 in vitro and exhibits anti-inflammatory activity in vivo. The peptide and its physiologically acceptable organic or inorganic salts are valuable as therapeutic agents for treating dermatological and collagen inflammatory infections.

Career Highlights

Luca Parente is associated with Sclavo Spa, where he applies his knowledge and skills in the development of innovative therapeutic solutions. His work at Sclavo Spa has positioned him as a key player in the pharmaceutical industry, contributing to advancements in treatment options for inflammatory diseases.

Collaborations

Luca collaborates with notable colleagues, including Mauro Perretti and Cristina Becherucci. Their combined expertise fosters a productive research environment, enhancing the potential for groundbreaking discoveries in the field of anti-inflammatory therapies.

Conclusion

Luca Parente's innovative work in the development of anti-inflammatory peptides highlights his significant contributions to medical science. His patent and collaborations reflect a commitment to advancing therapeutic options for patients suffering from inflammatory conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…